Non-Functional Pancreatic Neuroendocrine Tumor: an Enigma
Abstract
Pancreatic neuroendocrine tumors (PNET) are rare
and complex neoplasms. They can either present as a
sporadic tumor or as part of various familial syndromes.
Clinical presentation depends on whether the tumor
expresses hormones and also whether the hormones
expressed, can produce symptoms. Diagnosis can be
delayed in non-functional PNET and can have metastatic
disease at the time of presentation. Management depends
on the location and extent of the tumour. This article
presents a case series of non-functional neuroendocrine
tumors managed in our institute.
Full Text:
PDFReferences
I. M. Modlin, S. F. Moss, B. I. Gustafsson, B. Lawrence, S.
Schimmack, and M. Kidd, “The archaic distinction between
functioning and non-functioning neuroendocrine neoplasms
is no longer clinically relevant,” Langen beck’s Archives of
Surgery, vol. 396, no. 8, pp. 1145–1156, 2011.
J. C. Yao, M. Hassan, A. Phan et al., “One hundred years
after ‘carcinoid’: epidemiology of and prognostic factors for
neuroendocrine tumors in 35,825 cases in the United
States,” Journal of Clinical Oncology, vol. 26, no. 18, pp.
–3072, 2008.
D. C. Metz and R. T. Jensen, “Gastrointestinal
neuroendocrine tumors: pancreatic endocrine tumors,”
Gastroenterology, vol. 135, no. 5, pp. 1469–1492, 2008
K. E. Oberg, “Gastrointestinal neuroendocrine tumors,”
Annals of Oncology, vol. 21, 7, no. 7, pp. vii72-vii80, 2010.
M. H. Kulke, L. B. Anthony, D. L. Bushnell et al.,
“NANETS treatment guidelines: Well-differentiated
neuroendocrine tumors of the stomach and pancreas,”
Pancreas, vol. 39, no. 6, pp. 735–752, 2010.
Zerbi A, Falconi M, Rindi G, DelleFave G, Tomassetti P,
Pasquali C, Capitanio V, Boninsegna L, Di Carlo V.
Clinicopathological features of pancreatic endocrine tumors:
a prospectivemulticenter study in Italy of 297 sporadic
cases. Am J Gastroenterol. 2010;105:1421–1429.
Koukouraki S, Strauss LG, Georgoulias V, et al.
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in
patients with metastatic neuroendocrine tumours scheduled
for 90Y-DOTATOC therapy. Eur J Nucl Med. 2006;33:
–466.
Akerstrom G, Hellman P. Surgery on neuroendocrine
tumours. Best Pract Res ClinEndocrinolMetab 2007; 21:
–109.
Sarmiento JM, Que FG. Hepatic surgery for metastases
from neuroendocrine tumors. SurgOncolClin N Am 2003; 12:
–242.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr MGR Medical University